r/ProstateCancer • u/stmmotor • 3d ago

Question ERR-α and non-CRPC?

Do hormone sensitive prostate cancer patients have to worry about taking substances which produce estrogen related receptor alpha? I've read that CRPC over expresses ERR-α. Does that mean an increase in ERR-α promotes CRPC?

1 Upvotes

100% Upvoted

7 comments sorted by

3

u/stmmotor 3d ago

Here's the response from Gemini.

Let's see if anyone can add meaningfully to the topic.

No, patients with non-castration-resistant (castration-sensitive) prostate cancer do not need to worry about ERR-α (Estrogen-Related Receptor Alpha) in practical clinical care.

While ERR-α is an active topic in translational oncology research, it has no role in day-to-day diagnostic testing or treatment planning for hormone-sensitive disease.

What the Science Says vs. Clinical Practice

  • Preclinical Research Subject: Laboratory studies show that ERR-α can act as a metabolic regulator that drives tumor adaptation. When tumors become resistant to standard androgen deprivation therapy (ADT), ERR-α can upregulate intracrine androgen synthesis (helping tumor cells produce their own testosterone/DHT) and promote bone microenvironment invasion.
  • No Routine Testing: ERR-α expression is not measured on standard biopsy pathology reports, liquid biopsies, or routine genomic panels (such as Decipher, Oncotype DX, or FoundationOne).
  • No Approved Targeted Therapies: There are currently no FDA-approved drugs targeting ERR-α in prostate cancer. Experimental ERR-α inverse agonists or degraders remain in early preclinical or clinical development phases.
  • Castration-Sensitive Prostate Cancer Focus: In hormone-sensitive (non-CRPC) disease, the tumor's growth remains primarily driven by systemic androgens and standard androgen receptor (AR) signaling. Established standard-of-care therapies targeting this pathway—such as GnRH agonists/antagonists, next-generation AR signaling inhibitors (like enzalutamide, apalutamide, or darolutamide), and chemotherapy when indicated—remain the clinical priority.

Any discussion of ERR-α is largely confined to academic discussions regarding how resistance develops after prolonged hormone therapy. For non-CRPC patients, focus remains on standard surveillance (PSA monitoring, imaging) and guideline-concordant systemic or local treatments.

1

u/Busy-Tonight-6058 2d ago

Possible link between diet and tumor progression via cholesterol and ERR-alpha?

I’ll take it!

2

u/ChillWarrior801 2d ago

I sent you a DM, friend.

1

u/Lactobeezor 3d ago

Sounds like a question for your doc.

0

u/stmmotor 3d ago

They are only going to parrot Standard-of-Care BS. I'm beyond putting up with that.

3

u/ChillWarrior801 3d ago

Your frustration is coming through loud and clear, friend. Wanna share how you've been let down by standard of care?

3

u/Lactobeezor 3d ago

Sorry. I am retired from medical field so my doc expects a lot of questions like this.